US FTC ramps up improper patent crusade with investigation into Teva's inhaler IP: report 0 02.07.2024 17:04 Fiercepharma.com US FTC ramps up improper patent crusade with investigation into Teva's inhaler IP: report fkansteiner Tue, 07/02/2024 - 10:04
